Section on Hematopoiesis and Lymphocyte Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
MRC Human Immunology Unit, Weatherall Institute for Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.
Trends Immunol. 2017 Sep;38(9):622-632. doi: 10.1016/j.it.2017.06.006. Epub 2017 Jul 8.
THEMIS, a recently identified T-lineage-restricted protein, is the founding member of a large metazoan protein family. Gene inactivation studies have revealed a critical requirement for THEMIS during thymocyte positive selection, implicating THEMIS in signaling downstream of the T cell antigen receptor (TCR), but the mechanistic underpinnings of THEMIS function have remained elusive. A previous model posited that THEMIS prevents thymocytes from inappropriately crossing the positive/negative selection threshold by dampening TCR signaling. However, new data suggest an alternative model where THEMIS enhances TCR signaling enabling thymocytes to reach the threshold for positive selection, avoiding death by neglect. We review the data supporting each model and conclude that the preponderance of evidence favors an enhancing function for THEMIS in TCR signaling.
THEMIS 是一种最近被鉴定的 T 细胞谱系受限蛋白,是一个大型后生动物蛋白家族的创始成员。基因失活研究表明,THEMIS 在胸腺细胞阳性选择过程中是必需的,提示 THEMIS 参与 T 细胞抗原受体 (TCR) 信号下游,但其功能的机制基础仍然难以捉摸。先前的模型假设 THEMIS 通过抑制 TCR 信号来防止胸腺细胞不适当地跨越阳性/阴性选择阈值。然而,新的数据表明了另一种模型,即 THEMIS 增强 TCR 信号,使胸腺细胞能够达到阳性选择的阈值,从而避免因忽视而死亡。我们回顾了支持每种模型的数据,并得出结论,大多数证据支持 THEMIS 在 TCR 信号中具有增强功能。